Thromb Haemost 2006; 95(06): 1033-1034
DOI: 10.1160/TH06-02-0098
Case Report
Schattauer GmbH

Pregnancy in a woman with a history of Budd-Chiari syndrome treated by porto-systemic shunt, protein C deficiency and bicornuate uterus

Pasquale Martinelli
1   Obstetric and Gynaecological Emergency Unit, Department of Gynaecology, Obstetrics and Reproductive Physiopathology, Federico II University, Naples, Italy
,
Giuseppe Maria Maruotti
1   Obstetric and Gynaecological Emergency Unit, Department of Gynaecology, Obstetrics and Reproductive Physiopathology, Federico II University, Naples, Italy
,
Antonio Coppola
2   Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
,
Annalisa Agangi
1   Obstetric and Gynaecological Emergency Unit, Department of Gynaecology, Obstetrics and Reproductive Physiopathology, Federico II University, Naples, Italy
,
Dario Paladini
1   Obstetric and Gynaecological Emergency Unit, Department of Gynaecology, Obstetrics and Reproductive Physiopathology, Federico II University, Naples, Italy
,
Elvira Grandone
3   Atherosclerosis and Thrombosis Unit, IRCCS “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, Italy
,
Giovanni Di Minno
2   Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
3   Atherosclerosis and Thrombosis Unit, IRCCS “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, Italy
› Author Affiliations
Further Information

Publication History

Received 17 February 2006

Accepted after revision 09 May 2006

Publication Date:
30 November 2017 (online)

 

 
  • References

  • 1 Dilawary JP. et al. Hepatic outflow obstruction (Budd-Chiari Syndrome): experience with 177 patients and a review of the literature. Medicine 1994; 73: 21-36.
  • 2 Janssen HL. et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiences in coagulation factors associated with Budd-Chiari syndrome and portal vein thrombosis: Results of a case control study. Blood 2000; 96: 2364-8.
  • 3 Delentre P. et al. Factor V Leiden related Budd- Chiari syndrome. Gut 2001; 48: 264-8.
  • 4 Mohanty D. et al. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India. Hepatology 2001; 34: 666-70.
  • 5 De Stefano V. et al. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 1997; 23: 411-8.
  • 6 Pelletier S. et al. Antiphospholipid syndrome as the second cause of non- tumorous Budd-Chiari syndrome. J Hepatol 1994; 21: 76-80.
  • 7 Valla D. et al. Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives: a case-control study. Gastroenterology 1986; 90: 807-11.
  • 8 Mentha G. et al. Liver transplantation for Budd- Chiari syndrome: A European study on 248 patients from 51 centres. J Hepatol 2006; 44: 520-8.
  • 9 Rosenthal T. et al. The Budd-Chiari syndrome after pregnancy. Report of two cases and a review of the literature. Am J Obstet Gynecol 1972; 113: 789-92.
  • 10 Khuroo MS, Datta DV. Budd-Chiari syndrome following pregnancy. Report of 16 cases, with roentgenologic, hemodynamic and histologic studies of the hepatic outflow tract. Am J Med 1980; 68: 113-21.
  • 11 Vons C. et al. Successful pregnancy after Budd- Chiari syndrome. Lancet 1984; 02: 975.
  • 12 Marpeau L. et al. Normal pregnancy after a Budd- Chiari syndrome treated by shunting: apropos of a case, review of the literature [Article in French]. J Gynecol Obstet Biol Reprod (Paris) 1987; 16: 1045-52.
  • 13 Lee WM. Pregnancy in patients with chronic liver disease. Gastroenterol Clin North Am 1992; 21: 889-903.
  • 14 De Stefano V. et al. Inherited thrombophilia: pathogenesis, clinical syndromes and management. Blood 1996; 87: 3531-44.
  • 15 Friederich PW. et al. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient woman: implications for prophylaxis. Ann Intern Med 1996; 125: 955-60.
  • 16 Martinelli I. et al. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost 2001; 86: 800-3.
  • 17 Boda Z. et al. Low molecular weight heparin as thromboprophylaxis in familial thrombophilia during the whole period of pregnancy. Thromb Haemost 1996; 76: 124-8.
  • 18 Sanson BJ. et al. Safety of low molecular weight heparin in pregnancy: a systematic review. Thromb Haemost 1997; 77: 39-43.
  • 19 Iturbe-Alessio I. et al. Risks of anticoagulant therapy in pregnant woman with artificial heart valves. N EnglJ Med 1986; 315: 1390-3.
  • 20 Acien P. Reproductive performance of women with uterine malformations. Hum Reprod 1993; 08: 122-6.
  • 21 Bates SM. et al. Use of antithrombotic agents during pregnancy The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (Suppl. 03) 627S-644S.